Genting continues uptrend


Negative news from associate TauRX fails to halt stock's advance

SHARES of Genting Bhd continue to be on a roll despite the unfavourable news that an Alzheimer’s drug produced by its associate, TauRX Pharmaceuticals Ltd, has failed its experimental results.

Celebrate Merdeka with 50% Off!
T&C applies.

Monthly Plan

RM13.90/month
RM6.95 only

Billed as RM6.95 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM6.17/month

Billed as RM78 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Business , Genting

   

Next In Business News

HeiTech Padu bags RM133.73mil contract from JPJ
FBM KLCI ends on a high note; Property Index surges 2.26%
Japan says Seven & i now 'core' to national security
Battersea Power Station secures global marketing agency Team Lewis at 50 Electric Boulevard
Proton's maiden EV undergoes extensive on-road testing
Singapore stocks track 5th weekly gain; FX up on bets of big US rate cut
Oil extends recovery to cap volatile week
Boeing workers going on strike after 96% vote for walkout
China to implement zero tariffs for LDCs
Malaysia says its tech boom will withstand US election ripples

Others Also Read